Health News

Discover essential guidelines for properly wearing protective gear during the COVID-19 pandemic. Healthcare professionals share critical insights on using personal protective equipment effectively, addressing the challenges of PPE shortages and maintaining safety for frontline workers.

A man in Yunnan, China tested positive for hantavirus, causing widespread public concern about a potential new pandemic. Global Times reported the case, which quickly spread on social media, with some fearing another global health threat while the world still battles COVID-19.

The CDC's preliminary data reveals varying COVID-19 fatality rates across age groups. Individuals over 85 show the highest mortality risk, followed by those aged 65-84 years. Dr. Roger Seheult from MedCram discusses the critical findings from the March 18 report on severe outcomes in the United States.

A recent medical lecture by Dr. Roger Seheult discusses a pre-print study using rhesus macaques, indicating that initial COVID-19 infection might provide protection against reinfection. Researchers found no viral replication or pathological damage when re-exposing previously infected monkeys, suggesting potential natural immunity.

Global scientists are searching for effective coronavirus treatments. Israeli researchers propose that Angiotensin receptor blockers might offer a promising approach to reducing the aggressiveness and mortality of SARS-CoV-2 virus infections, based on initial observations and existing therapeutic options.

Singapore's government has awarded Arcturus Therapeutics a potentially $10 million grant to develop a unique coronavirus vaccine. The company claims its single-shot solution offers a 30-fold improvement in dosing, utilizing a self-replicating RNA platform in collaboration with Duke University and National University of Singapore.

Philippine President Rodrigo Duterte declared a state of public health emergency as COVID-19 cases rise in Manila. The proclamation allows financial assistance to local governments and eases procurement of health resources to combat the spreading coronavirus outbreak.

Japanese drugmaker Takeda Pharmaceutical is developing a promising coronavirus treatment using plasma-derived therapy. Researchers are seeking blood samples from recovered or vaccinated individuals to advance their potential cure for COVID-19, aiming to provide new hope in the global fight against the pandemic.

The coronavirus outbreak is causing significant disruptions in global medicine production, with China's factory closures impacting active pharmaceutical ingredient supplies. India, a major generic drug provider, faces potential shortages as 70% of its chemical ingredients come from China.

Moderna Inc. has rapidly developed an experimental coronavirus vaccine (mRNA-1273) within six weeks and shipped it to NIAID for initial Phase 1 clinical trials. The vaccine will be tested on 25 healthy adults to assess immune response, with full approval potentially taking up to a year.